{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:32:59Z","timestamp":1777984379251,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["NIHR133774"],"award-info":[{"award-number":["NIHR133774"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antihypertensive treatment is effective at reducing the risk of cardiovascular disease, but is associated with adverse events, particularly in older patients with frailty. As a result, deprescribing antihypertensive medications is recommended in some clinical guidelines despite limited evidence from a few small randomised controlled trials. The aim of the OPTIMISE2 trial is to examine the safety, efficacy and cost-effectiveness of deprescribing antihypertensive treatment in older adults with controlled systolic blood pressure, who are at higher risk of adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The OPTIMISE2 trial aims to enrol 3014 participants into the trial and actively follow them up for 1 year. Participants are aged 75\u00a0years and above and taking two or more blood pressure lowering drugs, with controlled blood pressure readings (systolic blood pressure\u2009&lt;\u2009140\u00a0mmHg if aged 75\u201379\u00a0years or\u2009&lt;\u2009150\u00a0mmHg if aged 80+\u2009years), frail and\/or at a higher risk of serious drug-related side effects of hypotension, syncope and falls. The trial randomises (1:1) participants to either step-down medication reduction (withdrawal of one antihypertensive medication at a time, at 4-week intervals with regular monitoring of blood pressure) or usual care (no medication reduction mandated). The choice of medications to withdraw is at the discretion of participating general practitioners or prescribers. The primary outcome is emergency hospitalisation or death within 1 year of randomisation. The primary objective is to determine whether antihypertensive deprescribing is non-inferior to usual care, with up to a 5% difference in the percentage of patients with an emergency hospitalisation\/death. The study uses a within-trial economic evaluation and decision-analytic modelling to estimate the cost-effectiveness of deprescribing antihypertensive treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>It is expected that these findings will inform clinical guidelines and practice about deprescribing of antihypertensive medications in older adults with frailty, who have controlled systolic blood pressure but are at higher risk of adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ISRCTN18030225. Registered on 19\/09\/2023.<\/jats:p>\n                    <jats:p>Secondary Identifying Numbers: University of Oxford Sponsor Protocol Number 16667. IRAS 1006598. CPMS 56390.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-026-09508-7","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T01:06:18Z","timestamp":1771031178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimising Prescription of Treatment In older patients with Mild hypertension at Increased risk of Serious adverse Events (OPTIMISE2): protocol for a primary care based, open-label, randomised controlled non-inferiority trial"],"prefix":"10.1186","volume":"27","author":[{"given":"Melanie","family":"Carr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Kenealy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ly-Mee","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Moschandreas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. D. Richard","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"de Lusignan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros","family":"Petrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milensu","family":"Shanyinde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"McCartney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Clegg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Mant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupert","family":"Payne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marney","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Ogden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"McManus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4461-8756","authenticated-orcid":false,"given":"James P.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"9508_CR1","unstructured":"NHS Digital. Health Survey for England 2016: Prescribed medicines. www.digital.nhs.uk: Health and Social Care Information Centre; 2017."},{"key":"9508_CR2","unstructured":"Office for National Statistics. Mid-year population estimates 2019. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates\/bulletins\/annualmidyearpopulationestimates\/mid2019estimates#ageing. 2020."},{"issue":"1","key":"9508_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/bcp.14589","volume":"87","author":"C Hughes","year":"2021","unstructured":"Hughes C. Appropriate and inappropriate polypharmacy\u2014choosing the right strategy. Br J Clin Pharmacol. 2021;87(1):84\u20136.","journal-title":"Br J Clin Pharmacol"},{"key":"9508_CR4","first-page":"2079","volume":"9","author":"TM Alhawassi","year":"2014","unstructured":"Alhawassi TM, Krass I, Bajorek BV, Pont LG. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging. 2014;9:2079\u201386.","journal-title":"Clin Interv Aging"},{"key":"9508_CR5","doi-asserted-by":"crossref","unstructured":"Oscanoa TJ, Lizaraso F, Carvajal A. Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol. 2017;73(6):759\u201370.","DOI":"10.1007\/s00228-017-2225-3"},{"issue":"6","key":"9508_CR6","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","volume":"80","author":"E Reeve","year":"2015","unstructured":"Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of \u201cdeprescribing\u201d with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254\u201368.","journal-title":"Br J Clin Pharmacol"},{"key":"9508_CR7","volume":"372","author":"A Albasri","year":"2021","unstructured":"Albasri A, Hattle M, Koshiaris C, Dunnigan A, Paxton B, Fox SE, et al. Association between antihypertensive treatment and adverse events: systematic review and meta-analysis. BMJ (Clinical research ed). 2021;372:n189.","journal-title":"BMJ (Clinical research ed)"},{"issue":"4","key":"9508_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004223","volume":"20","author":"JP Sheppard","year":"2023","unstructured":"Sheppard JP, Koshiaris C, Stevens R, Lay-Flurrie S, Banerjee A, Bellows BK, et al. The association between antihypertensive treatment and serious adverse events by age and frailty: a cohort study. PLoS Med. 2023;20(4):e1004223.","journal-title":"PLoS Med"},{"key":"9508_CR9","unstructured":"National Guideline Centre. National Institute for Health and Care Excellence. Hypertension in adults: diagnosis and management [NICE guideline 136]. London: Royal College of Physicians (UK); 2019."},{"issue":"33","key":"9508_CR10","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"issue":"20","key":"9508_CR11","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1001\/jama.2020.4871","volume":"323","author":"JP Sheppard","year":"2020","unstructured":"Sheppard JP, Burt J, Lown M, Temple E, Lowe R, Fraser R, et al. Effect of antihypertensive medication reduction vs usual care on short-term blood pressure control in patients with hypertension aged 80 years and older: the OPTIMISE randomized clinical trial. JAMA. 2020;323(20):2039\u201351.","journal-title":"JAMA"},{"issue":"8","key":"9508_CR12","doi-asserted-by":"publisher","first-page":"e563","DOI":"10.1016\/S2666-7568(24)00131-4","volume":"5","author":"JP Sheppard","year":"2024","unstructured":"Sheppard JP, Temple E, Wang A, Smith A, Pollock S, Ford GA, et al. Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial. The Lancet Healthy Longevity. 2024;5(8):e563\u201373.","journal-title":"The Lancet Healthy Longevity"},{"issue":"9","key":"9508_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-022930","volume":"8","author":"JP Sheppard","year":"2018","unstructured":"Sheppard JP, Burt J, Lown M, Temple E, Benson J, Ford GA, et al. OPtimising treatment for mild systolic hypertension in the elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trial. BMJ Open. 2018;8(9):e022930.","journal-title":"BMJ Open"},{"issue":"8","key":"9508_CR14","doi-asserted-by":"publisher","first-page":"e563","DOI":"10.1016\/S2666-7568(24)00131-4","volume":"5","author":"JP Sheppard","year":"2024","unstructured":"Sheppard JP, Lown M, Temple E, Ford GA, Hobbs FDR, Little P, et al. Effect of antihypertensive deprescribing on serious adverse events, mortality, and cardiovascular disease: Long-term follow-up of the OPTiMISE randomised controlled trial. Lancet Healthy Longevity. 2024;5(8):e563\u201373.","journal-title":"Lancet Healthy Longevity"},{"key":"9508_CR15","doi-asserted-by":"crossref","unstructured":"Horne RW, J.; Hankins, M. The Beliefs about Medicines Questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:1\u201324.","DOI":"10.1080\/08870449908407311"},{"issue":"10","key":"9508_CR16","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of life research\u202f: an international journal of quality of life aspects of treatment, care and rehabilitation. 2011;20(10):1727\u201336.","journal-title":"Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation"},{"key":"9508_CR17","doi-asserted-by":"crossref","unstructured":"Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. the index of adl: a standardized measure of biological and psychosocial function. Jama. 1963;185:914\u20139.","DOI":"10.1001\/jama.1963.03060120024016"},{"issue":"3","key":"9508_CR18","doi-asserted-by":"publisher","DOI":"10.2196\/19773","volume":"6","author":"S de Lusignan","year":"2020","unstructured":"de Lusignan S, Jones N, Dorward J, Byford R, Liyanage H, Briggs J, et al. The Oxford Royal College of General Practitioners Clinical Informatics Digital Hub: Protocol to Develop Extended COVID-19 Surveillance and Trial Platforms. JMIR Public Health Surveill. 2020;6(3):e19773.","journal-title":"JMIR Public Health Surveill"},{"key":"9508_CR19","unstructured":"British and Irish Hypertension Society. How to measure Blood Pressure https:\/\/bihsoc.org\/resources\/bp-measurement\/measure-blood-pressure\/2007 [Available from: https:\/\/bihsoc.org\/resources\/bp-measurement\/measure-blood-pressure\/."},{"issue":"3","key":"9508_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ageing\/afw039","volume":"45","author":"A Clegg","year":"2016","unstructured":"Clegg A, Bates C, Young J, Ryan R, Nichols L, Ann Teale E, et al. Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing. 2016;45(3):353\u201360.","journal-title":"Age Ageing"},{"key":"9508_CR21","doi-asserted-by":"publisher","unstructured":"Archer L, Koshiaris C, Lay-Flurrie S, Snell KIE, Riley RD, Stevens R, Banerjee A, Usher-Smith JA, Clegg A, Payne RA, Hobbs FDR, McManus RJ, Sheppard JP; STRAtifying Treatments In the multi-morbid Frail elderlY (STRATIFY) investigators. Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study. BMJ. 2022;379:e070918. https:\/\/doi.org\/10.1136\/bmj-2022-070918. Erratum in: BMJ. 2023;383:p2267. https:\/\/doi.org\/10.1136\/bmj.p2267.","DOI":"10.1136\/bmj-2022-070918"},{"key":"9508_CR22","doi-asserted-by":"publisher","unstructured":"Koshiaris C, Wang A, Archer L, Riley RD, Snell KI, Stevens RJ, Banerjee A, Swain S, Clegg A, Clark CE, Payne RA, Hobbs FDR, Ogden M, McManus RJ, Sheppard JP; STRATIFY investigators. Predicting hypotension, syncope, and fracture risk in patients indicated for antihypertensive treatment: the STRATIFY models. Nat Commun. 2025;16(1):9371. https:\/\/doi.org\/10.1038\/s41467-025-64408-9.","DOI":"10.1038\/s41467-025-64408-9"},{"issue":"9","key":"9508_CR23","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/j.1468-1331.2006.01512.x","volume":"13","author":"H Lahrmann","year":"2006","unstructured":"Lahrmann H, Cortelli P, Hilz M, Mathias CJ, Struhal W, Tassinari M. EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol. 2006;13(9):930\u20136.","journal-title":"Eur J Neurol"},{"issue":"1","key":"9508_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08870440290001494","volume":"17","author":"R Moss-Morris","year":"2002","unstructured":"Moss-Morris R, Weinman J, Petrie K, Horne R, Cameron L, Buick D. The Revised Illness Perception Questionnaire (IPQ-R). Psychol Health. 2002;17(1):1\u201316.","journal-title":"Psychol Health"},{"issue":"4","key":"9508_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019413","volume":"8","author":"P Duncan","year":"2020","unstructured":"Duncan P, Murphy M, Man M-S, Chaplin K, Gaunt D, Salisbury C. Development and validation of the Multimorbidity Treatment Burden Questionnaire (MTBQ). BMJ Open. 2020;8(4):e019413.","journal-title":"BMJ Open"},{"key":"9508_CR26","first-page":"200","volume":"2","author":"J Beecham","year":"2001","unstructured":"Beecham J, Knapp M. Costing psychiatric interventions. Measuring mental health needs. 2001;2:200\u201324.","journal-title":"Measuring mental health needs"},{"issue":"4","key":"9508_CR27","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/gps.5454","volume":"36","author":"A Burns","year":"2021","unstructured":"Burns A, Harrison JR, Symonds C, Morris J. A novel hybrid scale for the assessment of cognitive and executive function: The Free-Cog. Int J Geriatr Psychiatry. 2021;36(4):566\u201372.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"12","key":"9508_CR28","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s40266-016-0410-1","volume":"33","author":"E Reeve","year":"2016","unstructured":"Reeve E, Low LF, Shakib S, Hilmer SN. Development and Validation of the Revised Patients\u2019 Attitudes Towards Deprescribing (rPATD) Questionnaire: Versions for Older Adults and Caregivers. Drugs Aging. 2016;33(12):913\u201328.","journal-title":"Drugs Aging"},{"key":"9508_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.619088","volume":"12","author":"JP Sheppard","year":"2021","unstructured":"Sheppard JP, Lown M, Burt J, Ford GA, Hobbs FDR, Little P, et al. Blood Pressure Changes Following Antihypertensive Medication Reduction, by Drug Class and Dose Chosen for Withdrawal: Exploratory Analysis of Data From the OPTiMISE Trial. Front Pharmacol. 2021;12:619088.","journal-title":"Front Pharmacol"},{"key":"9508_CR30","doi-asserted-by":"crossref","unstructured":"Sheppard JP, Benetos A, McManus RJ. Antihypertensive Deprescribing in Older Adults: a Practical Guide. Current Hypertension Reports. 2022.","DOI":"10.1007\/s11906-022-01215-3"},{"issue":"8","key":"9508_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003482","volume":"3","author":"J Hippisley-Cox","year":"2013","unstructured":"Hippisley-Cox J, Coupland C. Predicting risk of emergency admission to hospital using primary care data: derivation and validation of QAdmissions score. BMJ Open. 2013;3(8):e003482.","journal-title":"BMJ Open"},{"key":"9508_CR32","unstructured":"Public Health England. Older people\u2019s hospital admissions in the last year of life 2017. https:\/\/www.gov.uk\/government\/publications\/older-peoples-hospital-admissions-in-the-last-year-of-life\/older-peoples-hospital-admissions-in-the-last-year-of-life. 2020.\u00a0"},{"key":"9508_CR33","unstructured":"National Institute for Health and Care Excellence. NICE health technology evaluations: the manual. https:\/\/www.nice.org.uk\/process\/pmg36\/chapter\/introduction-to-health-technology-evaluation; 2022."},{"issue":"2","key":"9508_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40273-022-01218-7","volume":"41","author":"M Hern\u00e1ndez Alava","year":"2023","unstructured":"Hern\u00e1ndez Alava M, Pudney S, Wailoo A. Estimating the relationship between EQ-5D-5L and EQ-5D-3L: results from a UK population study. Pharmacoeconomics. 2023;41(2):199\u2013207.","journal-title":"Pharmacoeconomics"},{"key":"9508_CR35","doi-asserted-by":"crossref","unstructured":"Jowett S, Kodabuckus S, Ford GA, Hobbs FDR, Lown M, Mant J, et al. Cost-Effectiveness of Antihypertensive Deprescribing in Primary Care: a Markov Modelling Study Using Data From the OPTiMISE Trial. Hypertension (Dallas, Tex : 1979). 2022;79(5):1122\u201331.","DOI":"10.1161\/HYPERTENSIONAHA.121.18726"},{"key":"9508_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision modelling for health economic evaluation","author":"A Briggs","year":"2006","unstructured":"Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. New York, USA: Oxford Unviversity Press; 2006."},{"key":"9508_CR37","unstructured":"National Institute for Health and Care Excellence (NICE). Multimorbidity and polypharmacy: Key therapeutic topic (KTT18). https:\/\/www.nice.org.uk\/advice\/ktt18\/chapter\/evidence-context#reviewing-polypharmacy-and-deprescribing; 2019."},{"issue":"12","key":"9508_CR38","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J Hypertens. 2023;41(12):1874\u20132071.","journal-title":"J Hypertens"},{"key":"9508_CR39","doi-asserted-by":"crossref","unstructured":"Gnjidic D, Langford AV, Jordan V, Sawan M, Sheppard JP, Thompson W, et al. Withdrawal of antihypertensive drugs in older people. Cochrane Data Syst Rev. 2025;3(3):Cd012572.","DOI":"10.1002\/14651858.CD012572.pub3"},{"key":"9508_CR40","doi-asserted-by":"crossref","unstructured":"Gautier S, Freminet A, Metz A, Georgiopopulos I, Labat C, Rossignol P, et al. Baseline data of a 3-year randomized controlled trial assessing the effects of the reduction of antihypertensive treatment in nursing home residents >80 yo. the retreat frail trial. J Hypertension. 2023;41(Suppl 3):e124.","DOI":"10.1097\/01.hjh.0000940020.06099.bf"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09508-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09508-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09508-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:56:31Z","timestamp":1774281391000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09508-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9508"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09508-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7048243\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This trial was approved by an NHS Research Ethics Committee (East Midlands - Leicester Central Research Ethics Committee. REC Ref: 23\/EM\/0054) and the Medicines and Healthcare Products Regulatory Authority (MHRA; ref CTA 21584\/0465\/001-0002) via combined review. Full approvals were received on 18th September 2023.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"220"}}